參考文獻/References:
[1] Yamamoto N, Tsuchiya H.Chemotherapy for osteosarcoma-where does it come from What is it Where is it going?[J].Expert Opin Pharmacother,2013, 14(16):2183-2193.
[2] 翁艷,陳冬冬,涂少臣,等.Cell-SELEX篩選人骨肉瘤細胞MG63核酸適配體的實驗研究[J].福建醫(yī)藥雜志,2018,40(2):111-114.
[3] 萬想,孟憲權(quán),劉義鶴.化學氣相沉積法制備GaN納米線及其形貌結(jié)構(gòu)和生長機理研究[J].功能材料,2014,45(2):02082-02085.
[4] 趙慶.微流控芯片用于循環(huán)腫瘤細胞高效捕獲的研究[D].長沙:湖南大學,2013.
[5] Nagrath S,Sequist L V,Maheswaran S,et al.Isolation of rare circulating tumor cells in cancer patients by microchip technology[J].Nature,2008,450(7173):1235-1239.
[6] Ahmed M G,Abate M F,Song Y,et al.Isolation, detection, and antigen-based profiling of circulating tumor cells using a size-dictated immunocapture chip[J].Angew Chem Int Ed, 2017, 56(36):10681-10685.
[7] Tellez-Gabrie M, Heymann M F, Heymann D.Circulating tumor cells as a tool for assessing tumor heterogeneity [J].Theranostics, 2019, 9(16): 4580-4594.
相似文獻/References:
[1]林文韜 王武煉 肖莉莉 張怡元.基于GEO數(shù)據(jù)庫發(fā)現(xiàn)骨肉瘤關(guān)鍵基因GMFG及其生物學功能[J].福建醫(yī)藥雜志,2020,42(02):112.
LIN Wentao,WANG Wulian,XIAO Lili,et al.Identification of the key gene GMFG and its biological function in osteosarcoma based on GEO database[J].FUJIAN MEDICAL JOURNAL,2020,42(02):112.
[2]陳劍明 陳國平.EGCG-CoPt NPs-Apt納米粒子對三陰乳腺癌細胞 MDA-MB-231增殖及遷移的影響[J].福建醫(yī)藥雜志,2020,42(05):126.
CHEN Jianming,CHEN Guoping.Effect of EGCG-CoPt NPs-Apt nanoparticles on proliferation and migration of triple negative breast cancer cells MDA-MB-231[J].FUJIAN MEDICAL JOURNAL,2020,42(02):126.
[3]陳康堯,顧恩毅,蔡碰德,等.H1受體拮抗劑異丙嗪對順鉑治療骨肉瘤的影響及機制[J].福建醫(yī)藥雜志,2021,43(04):132.
CHEN Kangyao,GU Enyi,CAI Pengde,et al.Efficacy and mechanism of H1 receptor antagonist promethazine on osteosarcoma treated with cisplatin[J].FUJIAN MEDICAL JOURNAL,2021,43(02):132.
[4]鐘志輝,林焱斌,莊 研,等.骨肉瘤組織ACTN4和CD133的表達及其影響因素[J].福建醫(yī)藥雜志,2021,43(05):117.
ZHONG Zhihui,LIN Yanbin,ZHUANG Yan,et al.Expression and interfering factors of ACTN4 and CD133 in osteosarcoma[J].FUJIAN MEDICAL JOURNAL,2021,43(02):117.
[5]林東澤.shRNA沉默c-myc基因?qū)G-63骨肉瘤細胞c-myc/PD-L1軸的影響[J].福建醫(yī)藥雜志,2022,44(05):133.
[6]周子杰,張家豪,姜吉霖,等.miR-586通過SFRP1調(diào)控骨肉瘤細胞增殖、遷移、侵襲的機制研究[J].福建醫(yī)藥雜志,2024,46(01):115.[doi:10.20148/j.fmj.2024.01.032]